ENA Respiratory Awarded $4.38 Million U.S. Department of Defense Agreement to Fund Development of Broad-Spectrum Antiviral INNA-051

-- Goal is to add new medical countermeasure (MCM) against known and emerging viral respiratory threats MELBOURNE, Australia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Clinical-stage pharmaceutical company

Related Keywords

Australia ,Melbourne ,Victoria ,Minderoo ,Western Australia ,Sydney ,New South Wales ,Kostenloser Wertpapierhandel ,Christophe Demaison ,Us Department Of Defense ,Defense Program ,Minderoo Foundation ,Other Transaction Authority ,Us Department Of Defense Do ,Dod Joint Program Executive Office For Chemical ,Pty Ltd ,Us Department Of Defense Chemical ,Nuclear Defense ,Joint Program Executive Office ,Defense Innovation Unit ,Investigational New Drug ,Biological Defense Program ,Finn Partners ,Brandon Capital Partner ,Respiratory ,Warded ,Billion ,Department ,Defense ,Agreement ,Fund ,Development ,Road ,Spectrum ,Antiviral ,Anna ,